Medicenna Therapeutics Corp.
MDNA.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.59M | -19.73M | -19.68M | -19.40M | -18.88M |
| Total Depreciation and Amortization | 37.90K | 25.40K | 13.20K | 5.80K | 2.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.20M | 8.12M | 7.52M | 7.27M | 6.27M |
| Change in Net Operating Assets | 915.90K | -364.80K | -222.80K | 953.90K | 547.70K |
| Cash from Operations | -11.84M | -11.95M | -12.37M | -11.18M | -12.06M |
| Capital Expenditure | -24.20K | -24.20K | -24.20K | -22.70K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.20K | -24.20K | -24.20K | -22.70K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 23.81M | 23.81M | 21.90M | 20.90M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.00K | -300.00K | -300.00K | -- | -- |
| Cash from Financing | 17.14M | 17.15M | 15.79M | 15.27M | -- |
| Foreign Exchange rate Adjustments | 633.20K | 784.70K | -13.40K | 197.00K | -264.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.91M | 5.96M | 3.38M | 4.27M | -12.32M |